Royal Bank of Canada’s Elevance Health ELV Stock Holding History

Royal Bank of Canada’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-25,000	Closed	-$5.49M	–	6582
2018 Q1	$5.49M	Buy	+25,000	New	+$5.87M	﹤0.01%	1935
2015 Q1	–	Sell	-47,600	Closed	-$5.98M	–	6204
2014 Q4	$5.98M	Hold	47,600	–	–	﹤0.01%	1546
2014 Q3	$5.69M	Hold	47,600	–	–	﹤0.01%	1558
2014 Q2	$5.12M	Buy	+47,600	New	+$4.9M	﹤0.01%	1637
2014 Q1	–	Sell	-30,000	Closed	-$2.77M	–	5955
2013 Q4	$2.77M	Buy	+30,000	New	+$2.67M	﹤0.01%	2048
2013 Q3	–	Sell	-29,100	Closed	-$2.38M	–	6132
2013 Q2	$2.38M	Buy	+29,100	New	+$2.18M	﹤0.01%	1947

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Royal Bank of Canada's ELV Position: Q1 2026 in Review

Royal Bank of Canada increased its Elevance Health (ELV) stake by 8.4% in Q1 2026, buying an estimated $12.6M and bringing the position to 495,383 shares worth $145M. The position accounts for 0.03% of the portfolio, ranked #510.

Royal Bank of Canada first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $519M in Q4 2022. 1,467 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Royal Bank of Canada held 495,383 shares of Elevance Health worth $145M as of Q1 2026.
Royal Bank of Canada bought 38,283 Elevance Health shares in Q1 2026, an estimated $12.6M.
Elevance Health made up 0.03% of Royal Bank of Canada's portfolio in Q1 2026, its #510 holding.
Royal Bank of Canada first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
Royal Bank of Canada's Elevance Health position peaked at $519M in Q4 2022.
1,467 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.